- Home
- TMQ vs MXCT Comparison
TMQ vs MXCT Comparison
Compare TMQ & MXCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMQ
- MXCT
- Stock Information
- Founded
- TMQ 2004
- MXCT 1999
- Country
- TMQ Canada
- MXCT United States
- Employees
- TMQ N/A
- MXCT N/A
- Industry
- TMQ Precious Metals
- MXCT Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- TMQ Basic Materials
- MXCT Health Care
- Exchange
- TMQ Nasdaq
- MXCT Nasdaq
- Market Cap
- TMQ 211.9M
- MXCT 239.2M
- IPO Year
- TMQ N/A
- MXCT 2021
- Fundamental
- Price
- TMQ $1.39
- MXCT $2.18
- Analyst Decision
- TMQ
- MXCT Strong Buy
- Analyst Count
- TMQ 0
- MXCT 1
- Target Price
- TMQ N/A
- MXCT $9.00
- AVG Volume (30 Days)
- TMQ 340.6K
- MXCT 875.7K
- Earning Date
- TMQ 07-09-2025
- MXCT 08-05-2025
- Dividend Yield
- TMQ N/A
- MXCT N/A
- EPS Growth
- TMQ N/A
- MXCT N/A
- EPS
- TMQ N/A
- MXCT N/A
- Revenue
- TMQ N/A
- MXCT $37,675,000.00
- Revenue This Year
- TMQ N/A
- MXCT $8.82
- Revenue Next Year
- TMQ N/A
- MXCT $21.12
- P/E Ratio
- TMQ N/A
- MXCT N/A
- Revenue Growth
- TMQ N/A
- MXCT N/A
- 52 Week Low
- TMQ $0.47
- MXCT $2.00
- 52 Week High
- TMQ $2.09
- MXCT $5.20
- Technical
- Relative Strength Index (RSI)
- TMQ 52.77
- MXCT 45.26
- Support Level
- TMQ $1.34
- MXCT $2.13
- Resistance Level
- TMQ $1.53
- MXCT $2.32
- Average True Range (ATR)
- TMQ 0.07
- MXCT 0.12
- MACD
- TMQ 0.01
- MXCT 0.01
- Stochastic Oscillator
- TMQ 54.84
- MXCT 55.38
About TMQ Trilogy Metals Inc.
Trilogy Metals Inc is an exploration stage company engaged in mineral exploration. The company focuses on exploring and developing its mineral resource properties, which include the Upper Kobuk Mineral Projects (UKMP or UKMP Projects), in the Ambler mining district located in Alaska, the United States. Its properties include the Arctic copper-zinc-gold-silver project and other mineralized targets within a volcanogenic massive sulfide belt, and it also has a bornite carbonate-hosted copper project.
About MXCT MaxCyte Inc.
MaxCyte Inc is a commercial cell engineering company focused on providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics and to support cell-based research and development. The company has developed and commercialized a proprietary Flow Electroporation platform, which facilitates the complex engineering of a wide variety of cells. The Company has one reportable segment, cell engineering technology. The revenue is generated from the sale and licensing of company's instruments, as well as sales of single-use disposable processing assemblies.